Related Green Market Report Debuts With Intentions Of Becoming The 'CNBC Or Dow Jones Of Cannabis' Front Range Biosciences CEO Explains How Tissue Culture Can Help Marijuana Cultivators Drive Efficiency And Scale
As the cannabis industry matures, cultivators face new challenges.
One of the biggest issues right now is that of shrinking margins. In such a context, establishing low cost production facilities has become a priority.
The thing is, neither the U.S. nor Canada offer the option to create low cost structures due to numerous factors, including climate, labor costs and energy prices. Consequently, companies are starting to look overseas. While some like Avicanna are aiming at South America, others are considering options across the ocean. In this line, Cronos Group Inc (CVE: MJN) (OTC: PRMCF), one of the largest licensed cannabis producers in Canada, recently announced it entered a strategic joint venture to establish a medical marijuana production facility in Israel.
Best Medical Stocks For 2018: CVR Energy Inc.(CVI)
- [By elliottwave]
CVR Energy, Inc. (NYSE: CVI) is currently correcting the bullish 5 waves cycle from November 2016 low as a triple three structure reaching equal legs area $20.48 – $19.56 . The move can extend lower toward the 50-61.8 percent Fibonacci area ( $18.98 – $17.34 ) as a double three but will remain supported as the stock is still looking for a move higher toward at least $31 to finish 3 waves correcting 2014 cycle. If the stock fails to make new highs after bouncing from the current inflection area , then the pullback can extend lower against $12.03 low which should hold to allow CVI to the resume higher later on
- [By Robert Rapier]
CVR Partners’ fertilizer plant is located in Coffeyville, Kansas, adjacent to the refinery owned by CVR Refining (NYSE: CVRR). CVR Energy (NYSE: CVI), majority-owned by Carl Icahn via Icahn Enterprises (NYSE: IEP), is the general partner and owns most of the units for both CVR Partners and CVR Refining.
Best Medical Stocks For 2018: Immersion Corporation(IMMR)
- [By Lisa Levin]
Immersion Corporation (NASDAQ: IMMR) shares were also up, gaining 22 percent to $7.29. Immersion disclosed that Vic Viegas has agreed to resign as CEO and as a director. The company named Carl Schlachte as Interim CEO.
- [By Jim Robertson]
On Thursday, our Under the Radar Movers newsletter suggested shorting small cap technology stock Immersion Corporation (NASDAQ: IMMR):
We love how well developed the selling of Immersion shares has been. Rather than a sharp, v-shaped reversal — which may or may not follow through — we’ve seen a bowl-shaped transition from an uptrend to a downtrend. This ups the odds of downside follow-through, as there’s been no price “shock” to invite a sudden wave of buying.
- [By Lisa Levin]
Immersion Corporation (NASDAQ: IMMR) shares were also up, gaining 20 percent to $7.18. Immersion disclosed that Vic Viegas has agreed to resign as CEO and as a director. The company named Carl Schlachte as Interim CEO.
Best Medical Stocks For 2018: Estee Lauder Companies, Inc. (EL)
- [By WWW.THESTREET.COM]
GLP’s customers include Walmart (WMT) , Unilever (UL) , JD.com (JD) , Adidas (ADDYY) , Estee Lauder (EL) and L’Oreal (LRLCY) .
The S$3.38 offer price represents 81% premium over its 12-month volume weighted average price and a 25% premium over its last full trading day before the announcement.
- [By Ben Levisohn]
The 20 stocks meeting those requirements are: Ralph Lauren (RL), Time Warner(TWX), Twenty-First Century Fox(FOXA), PepsiCo(PEP), Estee Lauder(EL), Tesoro(TSO), XL(XL), Ameriprise Financial,(AMP), Unum(UNM), Merck(MRK), AbbVie(ABBV), Gilead Sciences(GILD), General Dynamics(GD), Alaska Air(ALK), United Continental(UAL), Delta Air Lines(DAL), Oracle(ORCL), eBay(EBAY), Apple(AAPL), and Centurylink(CTL).
Best Medical Stocks For 2018: Analog Devices, Inc.(ADI)
- [By ]
After ams reported the shortfall, the SOX index dipped to about 1% above its 200-day moving average. Among the worst performers on the index are Micron Technology Inc. (MU) , down 3.16% Monday, Skyworks Solutions Inc. (SWKS) , down 2.79%, and Analog Devices Inc. (ADI) , down 1.97%.
- [By Trey Thoelcke]
Analog Devices Inc. (NASDAQ: ADI) fiscal third-quarter results are scheduled for first thing Wednesday. The consensus earnings estimate is $1.15 per share, on $1.40 billion in revenue. The shares closed the week at $78.97. The consensus price target is $94.10, and the 52-week trading range is $59.01 to $90.49.
- [By ]
Crutcher added that TI’s own chip manufacturing teams have been pushing equipment suppliers to make their machinery smarter. “We want it to tell us sooner if there’s an issue with the [chip] wafer that’s going through that machine,” he said as an example. Fellow analog chip and microcontroller (MCU) suppliers such as Analog Devices (ADI) and Microchip (MCHP) also have strong industrial exposure.
- [By WWW.THESTREET.COM]
Chips from Texas Instruments (TXN) are built into a lot of devices that matter, Cramer said, and if investors want autonomous vehicles, they should be looking at Analog Devices (ADI) .
- [By ]
An Attractive Tech Stock At A Killer Price
This week, I’m recommending an income opportunity in Analog Devices (Nasdaq: ADI). It’s a stock that fared better than most in the recent selloff, a bullish indicator for the short term.
- [By Leo Sun]
If you think that Apple still has room to run, you should also check out three of its top suppliers — Cirrus Logic (NASDAQ:CRUS), Analog Devices (NASDAQ:ADI), and Skyworks Solutions (NASDAQ:SWKS) — which could all be lifted by the tech giant’s rally.
Best Medical Stocks For 2018: Bellerophon Therapeutics, Inc.(BLPH)
- [By William Romov]
Before we show you our pick, here are the top 10 penny stocks to watch this week
Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%
FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free
- [By Alex McGuire]
Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…
Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%
The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.